Vitamin D deficiency is associated with fractures. This relationship is biologically plausible. The results of 19 randomized clinical trials with vitamin D with or without calcium show varying results: a decreased fracture incidence in 7, neutral in 10 trials, whereas 2 trials with a high dose of vitamin D once per year showed an increased fracture incidence. In three out of four well-powered trials that used recommended doses of vitamin D 700-1000 IU per day, vitamin D supplementation did not significantly influence fracture risk. In one of these trials, a statistically significant fracture reduction was observed in nursing home residents having severe vitamin D deficiency, low calcium intake and good compliance. Thirteen meta-analyses were done, and 11 of these showed a significantly decreased fracture incidence in the supplemented groups. Vitamin D alone was not effective, studies combining vitamin D and calcium showed inconsistent results. Analyses for vertebral fractures were negative in all cases. In conclusion, a vitamin D supplement of 800 IU per day in combination with calcium may decrease the incidence of non-vertebral fractures, especially in persons in the older age groups having low-baseline vitamin D status and low calcium intake and showing good compliance.
Introduction
Vitamin D deficiency is associated with fractures in several epidemiological studies. [1] [2] [3] This association could be coincidental, as older persons get frail, and frail older persons are at high risk of fracture and vitamin D deficiency because they are less active and do not come outside in the sunshine. 1 However, in one of the studies, adjustment for physical activity levels did not change the results. 3 On the other side, a causal relationship is plausible because vitamin D deficiency (defined as a serum 25-hydroxyvitamin D (25(OH)D) level o50 nmol l À 1 ) leads to secondary hyperparathyroidism and increased bone resorption. 1, 4 In addition, the newly formed bone during high remodeling due to secondary hyperparathyroidism is less well mineralized. A randomized clinical trial with vitamin D 400 IU per day versus placebo showed a significant increase of bone mineral density in the hip, confirming a lower mineralization degree at the baseline. 5 The evidence for a causal relationship with fractures should come from randomized double-blind placebo-controlled trials. These trials have been done, but less than 50% showed a decreased incidence of fractures, whereas others did not show any effect or even a negative effect. 6 The Institute of Medicine concluded that vitamin D supplementation can have a moderate anti-fracture effect. 7 However, the US Preventive Services Task Force advised against vitamin D supplementation for the prevention of fractures. 8 This review discusses the rationale and mechanistic evidence, summarizes the data from 19 randomized clinical trials and discusses the high number of meta-analyses that have been done. It also discusses the conclusions from the Institute of Medicine and the US Preventive Services Task Force. The review ends with a conclusion and advice for further research.
Rationale
In the elderly, a negative calcium balance is common, due to low dietary calcium intake and vitamin D deficiency, resulting in lower calcium absorption from the gut. This negative calcium balance causes secondary hyperparathyroidism, an increase in bone resorption and lower mineralization of newly formed bone. When vitamin D deficiency is severe and longstanding, the newly formed bone matrix, the osteoid, will not mineralize, leading to accumulation of osteoid tissue and osteomalacia. 1 In a forensic autopsy study, osteoid volume was higher than 5% in 4.8% of the cases and higher than 10% in 1% of the cases. 9 In population-based studies, bone mineral density is positively correlated with vitamin D status. 10 In the National Health and Nutrition Examination Survey, bone mineral density increased about 5% when serum 25(OH)D increased from 20-80 nmol l 11 Vitamin D deficiency was associated with hip fractures and other fractures in several epidemiological studies. [1] [2] [3] Vitamin D deficiency may cause falls, as shown in epidemiological studies. 12 Probably muscle weakness and postural instability are involved. Vitamin D status was strongly associated with physical performance, measured by a walking test, five-chair stands and the tandem stand, in the LASA and B-PROOF cohorts. 13, 14 However, the presence of the vitamin D receptor in muscle tissue has been debated. 15 
Clinical Trials
From 1992 onward, 19 randomized controlled clinical trials on the effect of vitamin D supplementation with or without calcium on fracture incidence have been reported. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] The results of these trials are summarized in Table 1 . Thirteen of these were randomized double-blind placebo-controlled trials and six were randomized controlled trials without placebo. The vitamin D dose varied between 300 IU once per day and 500 000 IU once per year. In 11 trials, the vitamin D supplement was combined with a calcium supplement between 500 and 1200 mg of elementary calcium per day, usually 1000 mg per day. Fracture incidence decreased significantly in five trials. 16, 17, 19, 23, 24 One trial showed a borderline-decreased incidence of fractures 21 and in another very large trial, the Women's Health Initiative, a decreased hip fracture incidence was observed in the per protocol analysis only. 28 In 10 trials, fracture incidence did not decrease, but in three of these a decreased fall incidence was seen. In two trials with one high dose vitamin D per year, orally or by injection, compared with placebo, 31, 33 an increase of fracture incidence was observed. In one of these, fall incidence also increased in the vitamin D group. 33 The results of the vitamin D trials vary widely, even in the nine trials that used recommended doses of vitamin D 700-1000 IU per day in combination with calcium. This may indicate that the participants of the trials were not vitamin D-deficient or had already a high calcium intake. In addition, the fracture incidence might have been too low or the study was not adequately powered. This was not the case in the trials of Chapuy et al., Grant et al., Porthouse et al. and Salovaara et al. 16, 26, 27, 34 In three of these trials, vitamin D supplementation was not significantly associated with a reduced fracture risk. The only significant effect was observed in the trial of Chapuy et al., which was performed in persons living in nursing home or apartment houses for the elderly. The participants in this trial had severe vitamin D deficiency (see data in Table 1 after cross-calibration, 35 and low calcium intake. The average baseline 25(OH)D levels in this trial were the lowest of all trials. The compliance with therapy was high as the medication was distributed daily in the nursing homes. The number needed to treat for prevention of one nonvertebral fracture in this trial can be calculated as 26 . This shows what can be accomplished with adequate dosing in a welltargeted study. In community-dwelling older persons having higher average serum 25(OH)D levels, the effect of vitamin D on fracture incidence may be smaller than claimed.
Meta-analyses
From 2005 till now, 13 meta-analyses on clinical trials for fracture prevention have been published. [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] These meta-analyses are summarized in Table 2 . The authors have subdivided the meta-analyses according to vitamin D dose, 
Discussion
Clinical trials with a significant decrease of fracture incidence combined vitamin D and calcium with two exceptions, the Heikinheimo and Trivedi trial. 17, 23 In general, a dose-response effect was visible, but even a low dose of 400 IU per day showed a decreased fracture incidence in the per protocol analysis in the Women's Health Initiative trial. 28 A great number of meta-analyses has been performed with varying results. These meta-analyses or their subanalyses consistently showed that vitamin D alone is insufficient for fracture risk reduction. 37, 38, 43, 45, 48 This is not surprising as the aforementioned negative calcium balance in elderly individuals often results from vitamin D deficiency and low calcium intake. Adding calcium supplements to vitamin D indeed resulted in a significant 12-26% reduction of fracture risk in these 37, 43, 45, 48 and other 36, 39, 42, 44 (subanalyses of) meta-analyses. However, despite the combination of vitamin D and calcium, other meta-analyses failed to show a consistent reduction in fracture risk. 36, 38, 40, 41, 43, [45] [46] [47] [48] [49] Factors that may explain these inconsistent results include an inadequate dose of vitamin D, different baseline values of vitamin D and therapeutic non-compliance with the supplements. 50 First, fracture prevention requires an adequate dose of vitamin D. This was shown in the meta-analyses of BischoffFerrari et al., 36, 44, 49 in which 700-800 IU or at least a dose in excess of 400 IU of vitamin D was required to reduce fracture risk. Second, inconsistencies in the results of the metaanalyses might also be explained by different baseline values of serum 25(OH)D. Indeed, routine supplementation to the population is not effective, but should be targeted to persons with vitamin D deficiency and a low calcium intake. This can be illustrated by the RECORD trial of Grant et al., 26 in which the combination of 800 IU of vitamin D and 1000 mg calcium failed to show a reduction in fracture risk. Most of the participants in this trial were mobile, healthy and community-dwelling individuals, who are less likely to have calcium or vitamin D deficiency and to benefit from substitution. On the contrary, in older (475 years of age) or institutionalized persons and patients with osteoporosis, a low level of serum 25(OH)D (o20 ng ml À 1 ) is highly prevalent 1 and these persons will therefore benefit most from substitution therapy. This is illustrated by the first double-blind trial by Chapuy et al. 16 in Lyon, where 3204 severely deficient nursing home residents with low calcium intake were treated with vitamin D 800 IU per day and calcium 1200 mg per day versus double placebo. The high fracture incidence reduction in this trial can be explained by the poor vitamin D status and very low calcium intake in this frail nursing home population. Thus, supplementation will only be effective when targeted to individuals with documented or at high risk of deficiencies and those with a high fracture risk. 51 This may explain why in the meta-analyses of Cranney et al. 40 and Chung et al. 48 vitamin D supplementation reduced fracture risk in institutionalized but not in community-dwelling individuals. Most meta-analyses, however, do not provide information about baseline vitamin D status, and lack of targeting the supplements to persons with insufficiencies might explain at least some of the inconsistent results of these metaanalyses. Likewise, the inclusion of individual trials which allowed non-protocol calcium intake such as the WHI trial 28 might explain why some meta-analyses did not find an additional effect of calcium supplements besides vitamin D. 44 Finally, also differences in therapeutic compliance might explain the different results of the meta-analyses. Indeed, to prevent osteoporotic fractures, compliance and persistence with calcium and vitamin D are essential as the inhibitory effects of calcium and vitamin D on bone resorption are short-lived and cease when supplementation is discontinued. However, even in relatively healthy participants in studies like the WHI 28 and the RECORD trial, 26 compliance with supplementation was only 40-60%. The negative outcome of these trials can, at least partly, be explained by non-compliance and influences the result of meta-analyses in which these individual trials weight heavily. 40, 41 Compliance in nursing homes usually is high, as medication is distributed by nurses, and this may also explain the high fracture incidence reduction in the study of Chapuy et al. 16 Also in the meta-analysis of the DIPART group, 45 the inconsistent fracture risk reduction with a reduction in fracture risk in the subanalysis of 400 IU of vitamin D and 1000 mg calcium but no reduction in the subanalysis of 400-800 IU of vitamin D and 1000 mg calcium might be explained by poor compliance in some of the studies with a higher dose of vitamin D. Exclusion of trials with a compliance rate of less than 80% doubled the reduction of fracture risk in the meta-analysis of Tang et al. 39 It is however not excluded that 'healthy adherer bias' might explain this association between better compliance with osteoporosis medication and reduction in fracture risk. The protective effect on fracture risk of a healthy lifestyle in compliers might indeed be falsely attributed to osteoporosis treatment. This was illustrated in a recent analysis of the placebo arm of the WHI trial, in which a better adherence to placebo also reduced fracture risk. 52 Cadarette et al. 53 however found little evidence of healthy adherer bias when examining the association between better compliance to osteoporosis medication and reduction of fracture risk, with only better compliance to osteoporosis treatment reducing fracture risk. The varying outcomes of different clinical trials and the different conclusions from the many meta-analyses can only partly be explained by baseline vitamin D status, vitamin D dose, study population and compliance with supplementation. In addition, higher, infrequent doses may be harmful. 31, 33 This explains the prudent approach of the Institute of Medicine, 7 recommending vitamin D 800 IU per day or less, whereas the Endocrine Society recommended much higher doses. 54 The conclusion of the US Preventive Services Task Force even is more cautious, stating that the current evidence is insufficient to recommend vitamin D 4400 IU per day and calcium 41000 mg per day, whereas lower doses are not recommended at all. 8 The discussion is ongoing and results of further trials are to be awaited. 55 
Conclusion
The overall effect of vitamin D supplementation on fracture risk depends on the combination with calcium, the dose of vitamin D and the compliance with the supplements, and 
